Ghost Tree Capital, LLC Cytokinetics Inc Transaction History

Ghost Tree Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$47.86 - $75.05 $631,752 - $990,660	13,200 Added 66.0%	33,200 $1.8 Million
Q1 2024 May 15, 2024	BUY	$63.75 - $108.06 $637,500 - $1.08 Million	10,000 Added 100.0%	20,000 $1.4 Million
Q4 2023 Feb 14, 2024	SELL	$26.88 - $83.49 $2.15 Million - $6.68 Million	-80,000 Reduced 88.89%	10,000 $834,000
Q3 2023 Nov 14, 2023	BUY	$29.46 - $36.61 $2.65 Million - $3.29 Million	90,000 New	90,000 $2.65 Million

407

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.31B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.